JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


The Journal of Nuclear Medicine Vol. 41 No. 5 887-895
© 2000 by Society of Nuclear Medicine
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zinn, K. R.
Right arrow Articles by Rogers, B. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zinn, K. R.
Right arrow Articles by Rogers, B. E.

Noninvasive Monitoring of Gene Transfer Using a Reporter Receptor Imaged with a High-Affinity Peptide Radiolabeled with 99mTc or 188Re

Kurt R. Zinn, Donald J. Buchsbaum, Tandra R. Chaudhuri, James M. Mountz, William E. Grizzle and Buck E. Rogers

Departments of Radiology, Radiation Oncology, and Pathology, University of Alabama at Birmingham, Birmingham, Alabama

Correspondence: For correspondence or reprints contact: Kurt R. Zinn, DVM, PhD, University of Alabama at Birmingham, Dept. of Radiology, Division of Nuclear Medicine, BDB 11, 1530 3rd Ave. S., Birmingham, AL 35294-0012.

ABSTRACT

Gene therapy protocols require better modalities to monitor the location and level of transferred gene expression. One potential in vivo mechanism to assess gene expression would be to image the binding of a radiolabeled peptide to a reporter receptor that is expressed in targeted tissues. This concept was tested in a tumor model using a replication-incompetent adenoviral vector encoding the human type 2 somatostatin receptor (Ad5-CMVhSSTr2). Expression of the hSSTr2 reporter was imaged using a radiolabeled, somatostatin-avid peptide (P829). Methods: Bilateral subcutaneous A427 tumor xenografts were established on the flanks of athymic nude mice. These human-origin, non-small cell lung tumors are normally negative for hSSTr2 expression. One tumor was injected directly with Ad5-CMVhSSTr2, whereas the second tumor was injected directly with a control Ad5 vector. The mice were injected intravenously 48 h later with P829 peptide that was radiolabeled to high specific activity with 99mTc (half-life, 6 h) or 188Re (half-life, 17 h). Tumors were frozen and evaluated for somatostatin receptor expression using fluorescein-labeled somatostatin. Results: The accumulation of radiolabeled P829 in hSSTr2-expressing tumors was easily visualized by {gamma} camera imaging 3 h after injection. Imaging region of interest analyses and biodistribution studies confirmed a 5- to 10-fold greater accumulation of both radiolabeled P829 peptides in the Ad5-CMVhSSTr2-injected tumors versus control tumors injected with control Ad5 vectors. Ad5-CMVhSSTr2-injected tumors accumulated 2.5-3.8 percentage injected dose per gram 3 h after injection. Only Ad5-CMVhSSTr2-injected tumors expressed somatostatin receptors, as determined by immunohistochemistry. Conclusion: These studies show the feasibility of imaging a 99mTc-labeled peptide's binding to a reporter receptor after in vivo gene transfer to tumor cells. The 188Re-labeled peptide worked equally well for this imaging approach and offers the additional advantage of energetic p decay with potential therapeutic efficacy. 99mTc and 188Re are generator produced, an advantage for widespread availability and low cost, and both radioisotopes can be imaged with existing, high-resolution modalities. There is great potential for using 99mTc-labeled peptides for imaging gene transfer with the hSSTr2 reporter receptor, especially when the reporter correlates with the expression of therapeutic genes that can be included simultaneously in the gene therapy vector.

Key Words: imaging • gene transfer • somatostatin receptor • peptide • 99mTc • 188Re




This article has been cited by other articles:


Home page
JNMHome page
L. Chen, A. Altmann, W. Mier, H. Eskerski, K. Leotta, L. Guo, R. Zhu, and U. Haberkorn
Radioiodine Therapy of Hepatoma Using Targeted Transfer of the Human Sodium/Iodide Symporter Gene
J. Nucl. Med., May 1, 2006; 47(5): 854 - 862.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
J. M. Mathis, P. L. Stewart, Z. B. Zhu, and D. T. Curiel
Advanced Generation Adenoviral Virotherapy Agents Embody Enhanced Potency Based upon CAR-Independent Tropism.
Clin. Cancer Res., May 1, 2006; 12(9): 2651 - 2656.
[Full Text] [PDF]


Home page
Cancer Res.Home page
H. A. Ono, L. P. Le, J. G. Davydova, T. Gavrikova, and M. Yamamoto
Noninvasive Visualization of Adenovirus Replication with a Fluorescent Reporter in the E3 Region
Cancer Res., November 15, 2005; 65(22): 10154 - 10158.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
B. E. Rogers, J. J. Parry, R. Andrews, P. Cordopatis, B. A. Nock, and T. Maina
MicroPET Imaging of Gene Transfer with a Somatostatin Receptor-Based Reporter Gene and 94mTc-Demotate 1
J. Nucl. Med., November 1, 2005; 46(11): 1889 - 1897.
[Abstract] [Full Text] [PDF]


Home page
RadiologyHome page
D. Yang, L. Han, and V. Kundra
Exogenous Gene Expression in Tumors: Noninvasive Quantification with Functional and Anatomic Imaging in a Mouse Model
Radiology, June 1, 2005; 235(3): 950 - 958.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
D. J. Buchsbaum, T. R. Chaudhuri, and K. R. Zinn
Radiotargeted Gene Therapy
J. Nucl. Med., January 1, 2005; 46(1_suppl): 179S - 186S.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
L. Barzon, M. Boscaro, and G. Palu
Endocrine Aspects of Cancer Gene Therapy
Endocr. Rev., February 1, 2004; 25(1): 1 - 44.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
A. Hemminki, K. R. Zinn, B. Liu, T. R. Chaudhuri, R. A. Desmond, B. E. Rogers, M. N. Barnes, R. D. Alvarez, and D. T. Curiel
In Vivo Molecular Chemotherapy and Noninvasive Imaging With an Infectivity-Enhanced Adenovirus
J Natl Cancer Inst, May 15, 2002; 94(10): 741 - 749.
[Abstract] [Full Text] [PDF]


Home page
RadiologyHome page
K. R. Zinn, T. R. Chaudhuri, V. N. Krasnykh, D. J. Buchsbaum, N. Belousova, W. E. Grizzle, D. T. Curiel, and B. E. Rogers
Gamma Camera Dual Imaging with a Somatostatin Receptor and Thymidine Kinase after Gene Transfer with a Bicistronic Adenovirus in Mice
Radiology, March 21, 2002; (2002) 2232010501.
[Abstract] [Full Text]


Home page
JNMHome page
V. Kundra, F. Mannting, A. G. Jones, and A. I. Kassis
Noninvasive Monitoring of Somatostatin Receptor Type 2 Chimeric Gene Transfer
J. Nucl. Med., March 1, 2002; 43(3): 406 - 412.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
M. Iyer, L. Wu, M. Carey, Y. Wang, A. Smallwood, and S. S. Gambhir
Two-step transcriptional amplification as a method for imaging reporter gene expression using weak promoters
PNAS, December 4, 2001; 98(25): 14595 - 14600.
[Abstract] [Full Text] [PDF]


Home page
RadiologyHome page
A. Moore, L. Josephson, R. M. Bhorade, J. P. Basilion, and R. Weissleder
Human Transferrin Receptor Gene as a Marker Gene for MR Imaging
Radiology, October 1, 2001; 221(1): 244 - 250.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
O. C. Boerman, W. J.G. Oyen, and F. H.M. Corstens
Progress in Gene Therapy: Seeing Is Believing
J. Nucl. Med., August 1, 2001; 42(8): 1235 - 1237.
[Full Text] [PDF]


Home page
JNMHome page
J.-L. C. Urbain
Reporter Genes and Imagene
J. Nucl. Med., January 1, 2001; 42(1): 106 - 109.
[Full Text] [PDF]


Home page
RadiologyHome page
K. R. Zinn, T. R. Chaudhuri, V. N. Krasnykh, D. J. Buchsbaum, N. Belousova, W. E. Grizzle, D. T. Curiel, and B. E. Rogers
Gamma Camera Dual Imaging with a Somatostatin Receptor and Thymidine Kinase after Gene Transfer with a Bicistronic Adenovirus in Mice
Radiology, May 1, 2002; 223(2): 417 - 425.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 2000 by the Society of Nuclear Medicine.